openPR Logo
Press release

Sulfadiazine Sodium Injection Market Stand Out As The Biggest Contributor In Healthcare

02-27-2019 08:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Sulfadiazine Sodium

Sulfadiazine Sodium

Rising awareness for safe antibiotic uses due to widespread antibiotic resistance can drive high demand for sulfadiazine sodium injection in the global market during the forecast period. For instance, World Antibiotic Awareness Week (WAAW) observed every year in the month of November, purposes to increase global awareness of antibiotic resistance (AMR) and encourage best practices among public, health workers, and policy makers to avoid emergence and spread of antibiotic resistance.

Furthermore, the mission of Alliance for the Prudent Use of Antibiotics (APUA) started in 1981, is working to strengthen global defenses against infectious diseases by ensuring access to effective antibiotics treatment and promoting appropriate antibiotic use to reduce drug resistance. By 2018, APUA is working in 19 countries and stands as the world’s leading organization conducting research and education on antimicrobial treatment and resistance at the grassroots and global levels.

Sulfadiazine Sodium Injection Market– Restraint

Over the years, bacterial pathogens acquired resistance to sulfonamide class of antibiotics, due to mutations in pre-existing DNA, or by acquisition of antibiotic resistance genes (ARGs), which is expected to hinder growth of the sulfachloropyridazine sodium market. For instance, according to Centers for Disease Control and Prevention (CDC), in the U.S. doctors and emergency departments, prescribe at least 47 million antibiotic prescriptions each year, which are unnecessary. These are creating spread of antibiotics resistance, which might lead to severe consequences.

Get HOLISTIC Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2313

Sulfadiazine Sodium Injection Market– Regional Analysis

On the basis of region, the global sulfadiazine sodium injection market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is estimated to hold the leading position in sulfadiazine sodium injection market due to rising use of antibiotics. For instance, according to the U.S. Food and Drug Administration (USFDA) 2015, about 9.7 million kilograms (21.4 million pounds) of antibiotics considered important for human use were sold for use in animal agriculture.

Europe is also expected to witness significant growth in the global sulfadiazine sodium injection market, owing to rising awareness of antibiotics resistance and safe and effective practice of antibiotics use in the region. For instance, the European Antibiotic Awareness Day is celebrated on 18 November every year. On November 16, 2018, the symposium for the 11th European Antibiotic Awareness Day was hosted by the Federal Ministry for Labour, Social Affairs, Health and Consumer Protection in cooperation with the Austrian national reference centre. The agenda for the symposium focused on raising awareness about importance of prudent antibiotic use.

Sulfadiazine Sodium Injection Market– Competitive Analysis

Key players operating in the global sulfadiazine sodium injection market include, AdvaCare Pharma, Mercator Pharma, Shijiazhuang ZDHF Stock-Raising Co., Ltd, Pegasus Laboratories, Inc., Weifang Fubang Pharmaceutical Co., Ltd., Hebei Tianyuan Pharmaceutical Co., Ltd., Hebei Veyong Animal Pharmaceutical Co., Ltd., and GENERA d.d.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2313

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sulfadiazine Sodium Injection Market Stand Out As The Biggest Contributor In Healthcare here

News-ID: 1619918 • Views:

More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abbott Laboratories, Amway, Atkins, Blue Diamond Growers
Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb …
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth
Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion by 2032 with a 7.9% CAGR |C&D Technologies Inc., Crown Battery Manufacturing Co., East Penn Manufacturing Co. Inc., EnerSys
Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business
Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by 2025-2032 |Hangzhou Xunda Packaging Co., Smurfit Kappa Group PLC, DS Smith Plc, Pregis Corporation
Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by …
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,
Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koninklijke DSM N.V., BAE Systems, Morgan Advanced Materials , Saint-Gobain S.A.
Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni …
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,

All 5 Releases


More Releases for Sulfadiazine

Global Sulfadiazine Sodium Injection Market Future Prediction Report By 2032
The global sulfadiazine sodium injection market was valued at approximately USD 450 million in 2022 and is projected to reach around USD 750 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.5% from 2024 to 2032. Global Sulfadiazine Sodium Injection Market Overview The global sulfadiazine sodium injection market is witnessing steady growth, driven by its widespread use in treating bacterial infections, particularly in immunocompromised patients. Sulfadiazine sodium,
Sulfadiazine Market Research Report 2024 | Valuates Reports
The Sulfadiazine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sulfadiazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-35J3691/Global_Sulfadiazine_Market_Insights_Forecast_to_2028 For a more in-depth understanding of the
Global Sulfadiazine Industry Opportunities, Analysis & Forecasts, 2020-2029
Dhirtek Business Research and Consulting most recent study on the sulfadiazine market provides a comprehensive view of the entire market. The research report delves deeply into the global sulfadiazine market's drivers and restraints. Analysts have extensively researched the global sulfadiazine market's milestones and the current trends that are expected to determine its future. Primary and secondary research methods were used to create an in-depth report on the topic. Analysts have
Global Market Study on Silver Sulfadiazine
Global Silver Sulfadiazine Market: Snapshot The global silver sulfadiazine market is prognosticated to receive a robust growth in demand with the dire need for reliable medications to treat or prevent infection of wounds in patients with severe burns. Most of the time and for more effective usage, silver sulfadiazine is employed with other types of treatment. In order to protect an open wound from infection, silver sulfadiazine could work by ceasing
06-19-2017 | Health & Medicine
TMR
Silver Sulfadiazine Market 2014 Share, Trend, Segmentation and Forecast to 2020
Silver sulfadiazine is an antibacterial drug used for making personal care products such as anti-burn creams. Silver sulfadiazine is listed in the World Health Organization’s List of Essential Medicines and is widely used as an antibiotic for treating second and third degree burns on the skin. Silver sulfadiazine prevents the growth of bacteria and yeast on the skin. This drug is also commonly used to treat urinary tract infections (UTIs).
Global Silver Sulfadiazine Market Share by Industry Research 2014 - 2020
Silver sulfadiazine is an antibacterial drug used for making personal care products such as anti-burn creams. Silver sulfadiazine is listed in the World Health Organization’s List of Essential Medicines and is widely used as an antibiotic for treating second and third degree burns on the skin. Silver sulfadiazine prevents the growth of bacteria and yeast on the skin. This drug is also commonly used to treat urinary tract infections (UTIs).